Phase I Study of FXS0683 in the Treatment of Blood Tumors

Clinical trial NCT07616089 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07616089
Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B-Cell Lymphoma Acute Myeloid Leukemia Myelodysplastic Syndromes Acute Lymphoblastic Leukemia

Start date: 2026-06-01
Primary completion: 2028-08-07
Enrollment: 228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.